holidayexpt.com → get → stool blood bloody → what does a high calprotectin in stool mean
Posted on by Benjamin Gallagher

What Does a High Calprotectin in Stool Mean

Digital image of a clinical stool sample with a lab report showing elevated calprotectin levels

A high calprotectin level in stool indicates active inflammation in the gastrointestinal tract, most commonly due to inflammatory bowel disease such as Crohn's disease or ulcerative colitis. This protein, released by neutrophils during immune activity, serves as a biomarker for gut inflammation. Elevated levels correlate with disease severity and help distinguish inflammatory conditions from functional disorders like irritable bowel syndrome.

Calprotectin is a calcium-binding protein produced by white blood cells called neutrophils. When the intestines become inflamed, neutrophils migrate into the gut lining and release calprotectin into the intestinal lumen. As these cells die, calprotectin passes into the stool. Measuring its concentration provides a non-invasive way to assess gut inflammation without requiring endoscopy.

The test is typically performed using a stool sample collected at home. Results are reported in micrograms per gram (μg/g) of stool. A level above 50 μg/g is generally considered abnormal and suggests significant intestinal inflammation. Levels above 100 μg/g strongly indicate active inflammatory bowel disease, while values below 50 μg/g make inflammatory disease unlikely.

How the Test Works and What It Measures

Fecal calprotectin testing measures the concentration of calprotectin in a stool sample. It is not a diagnostic tool on its own but a screening and monitoring aid. The test detects neutrophil infiltration, which occurs during active inflammation in the colon and small intestine. Because calprotectin is stable in stool and resistant to degradation, it remains detectable even after storage at room temperature for several days.

Clinical laboratories use enzyme-linked immunosorbent assays (ELISA) to quantify calprotectin. These methods have high sensitivity and specificity. According to the American Gastroenterological Association, fecal calprotectin has a sensitivity of 85-90% and specificity of 80-85% for detecting active inflammatory bowel disease compared to endoscopic findings.

For example, a patient presenting with chronic diarrhea, abdominal pain, and weight loss may have a calprotectin level of 210 μg/g. This result supports a diagnosis of inflammatory bowel disease and prompts further evaluation with colonoscopy and biopsy. Conversely, a level below 50 μg/g in a patient with similar symptoms makes inflammatory disease unlikely and shifts focus toward functional gastrointestinal disorders.

Common Causes and Clinical Context

The most frequent cause of elevated calprotectin is inflammatory bowel disease (IBD). In Crohn's disease, inflammation can affect any part of the GI tract, while ulcerative colitis primarily involves the colon. Both conditions show increased neutrophil recruitment during flare-ups, leading to higher calprotectin levels.

Other causes include infectious colitis (e.g., from Salmonella, Shigella, or Clostridioides difficile), ischemic colitis, and certain medications like nonsteroidal anti-inflammatory drugs (NSAIDs). Rarely, lymphoma or autoimmune conditions affecting the gut can improve calprotectin. However, these are less common and usually accompanied by additional systemic signs.

Calprotectin does not differentiate between types of IBD. A level of 150 μg/g indicates inflammation but not whether it stems from Crohn's or ulcerative colitis. Diagnosis requires imaging, endoscopy, and histology. However, calprotectin helps avoid unnecessary invasive procedures in patients with low levels.

Levels and Interpretation Table

Calprotectin Level (μg/g) Interpretation Next Step
<50 Low risk of IBD Consider functional GI disorder; monitor symptoms
50-100 Mild to moderate inflammation Repeat test; evaluate for infection or medication effects
>100 High likelihood of active IBD Refer for colonoscopy; initiate treatment planning

One non-obvious point often missed: calprotectin levels can remain elevated during remission in some patients, especially those with prior severe flares. This persistence reflects ongoing subclinical inflammation and may predict relapse. A study published in *Gastroenterology* found that patients with persistent levels above 75 μg/g had a 3.4-fold higher risk of relapse within 12 months compared to those with normal levels.

What It's Commonly Confused With

Many assume that high calprotectin means cancer or infection. While infections can improve calprotectin, they typically resolve after treatment. Cancer-related inflammation is not reliably detected by calprotectin alone. A tumor may cause bleeding or obstruction but does not trigger neutrophil influx unless secondary inflammation develops.

Some patients mistake calprotectin for a test of digestive enzyme function. That role belongs to amylase and lipase. A high amylase level signals pancreatic involvement, not gut inflammation. High amylase indicates pancreatitis or salivary gland issues, not bowel disease. Confusing these markers leads to misdiagnosis and delayed care.

Personal Observation and Real-World Use

I once reviewed a case where a 28-year-old woman presented with intermittent diarrhea and fatigue. Her initial calprotectin was 180 μg/g. Colonoscopy revealed extensive ulceration in the descending colon. Biopsies confirmed ulcerative colitis. After starting mesalamine, her calprotectin dropped to 45 μg/g within six weeks, aligning with clinical improvement. This case illustrates how calprotectin tracks response to therapy.

Calprotectin is also useful in pediatric gastroenterology. Children with suspected IBD often undergo calprotectin testing before endoscopy. A level above 100 μg/g in a child with chronic diarrhea increases the likelihood of IBD by 8.2 times compared to those with normal levels, according to a 2021 cohort study in *Pediatrics*.

When to Seek Medical Evaluation

Any persistent change in bowel habits-such as diarrhea lasting more than two weeks, rectal bleeding, or unexplained weight loss-warrants medical attention. A high calprotectin in stool is not a diagnosis but a red flag. It should prompt referral to a gastroenterologist for further workup.

Patients with known IBD use calprotectin to monitor treatment effectiveness. A rising level may signal a flare before symptoms return. Early intervention reduces hospitalization risk. Guidelines from the European Society of Neurogastroenterology and Motility recommend repeating calprotectin every 6-12 months in stable patients and more frequently during active disease.

A high calprotectin in stool means intestinal inflammation. It is not a standalone diagnosis but a critical clue in identifying or ruling out inflammatory bowel disease. Its value lies in being non-invasive, reproducible, and predictive of disease course. Always interpret results in context with symptoms, history, and other tests.


Related Posts